Prostate cancer can develop quietly, without noticeable symptoms in its early stages. That is one reason screening and timely evaluation matter, particularly for men who have reached an age or risk level where it becomes appropriate.
Early detection usually begins with a PSA blood test. If the result is raised, a doctor may recommend a prostate MRI, and when a suspicious area is found, an MRI fusion biopsy can target it directly. A raised PSA does not automatically mean cancer, since it can also rise from an enlarged prostate, inflammation or infection. Screening simply flags men who may need further investigation before symptoms appear.
Why Can Prostate Cancer Stay Silent?
Early prostate cancer can grow without affecting urinary function or causing discomfort. Most cancers begin in the peripheral zone of the gland, away from the urethra, so they can reach a meaningful size before they press on anything that produces symptoms.
Symptoms such as frequent urination, a weak flow, waking at night to urinate, blood in the urine or erectile problems can occur with prostate cancer, but they are not specific to it and are far more commonly caused by benign enlargement. Many men with early prostate cancer have none of them at all.
That is why symptoms alone are not a reliable way to catch it early, and why a man who feels entirely well can still benefit from a conversation about testing.
What Does the PSA Test Actually Measure?
PSA is a protein made by prostate cells that normally circulates in small amounts. A raised result is a reason for further investigation, not a diagnosis. It can rise because of:
- Prostate cancer
- Benign prostate enlargement, which is by far the commonest cause
- Prostatitis or inflammation
- Urinary infection
- Recent prostate or urinary procedures, or a recent catheter
- Vigorous cycling or ejaculation shortly before the test
A single PSA number means little on its own. Doctors weigh it against age, previous results, prostate size, family history and examination findings, and increasingly against two further measures:
- PSA density: The PSA level divided by the prostate volume. This helps distinguish a raised PSA caused by a large benign gland from one that warrants a biopsy.
- Free-to-total PSA ratio: A lower proportion of free PSA suggests a higher likelihood of cancer.
These refinements matter because they help reduce the number of men sent for biopsies they did not need.
"A raised PSA is a reason to investigate, not a diagnosis. I have reassured far more men after a high PSA than I have diagnosed."
Dr. Himanshu Sharma, Consultant Urologist and Robotic Uro-Oncologist
How Does a Prostate MRI Help Before Any Biopsy?
A multiparametric prostate MRI gives detailed images of the gland and flags areas that look suspicious, though it cannot confirm cancer by itself. Its most valuable role is often the opposite one: a reassuring MRI can spare a man a biopsy altogether.
A scoring system called PI-RADS describes how suspicious an area appears, on a scale of 1 to 5, with a higher score meaning a greater likelihood of clinically significant cancer. The score is read alongside PSA density and examination findings rather than acted on in isolation.
The practical advantage is targeting. A traditional biopsy samples the prostate systematically, taking cores from set positions, which means a cancer sitting in an awkward location can be missed. MRI shows the doctor where to aim. Not every man needs an MRI, and not every abnormality seen on one turns out to be cancer.
What Happens During an MRI Fusion Biopsy?
An MRI fusion biopsy overlays the earlier MRI images onto real-time ultrasound, letting the doctor sample the suspicious area precisely while still taking systematic cores from the rest of the gland. A small number of tissue samples go to a pathologist for examination.
The route matters as much as the targeting. A biopsy can be taken through the rectal wall, which is the traditional approach, or through the perineum, the skin between the scrotum and the anus.
The transperineal route avoids passing the needle through the bowel, which substantially reduces the risk of serious infection. It also gives better access to the front of the prostate, where cancers are more easily missed. It has become the preferred approach in many centres.
Neither PSA nor MRI can confirm cancer on its own. The biopsy does that, and if cancer is found, the report also describes its type and grade.
What Does the Biopsy Report Actually Tell the Doctor?
The Gleason score and the resulting Grade Group describe how abnormal the cells look under the microscope and how aggressively they are likely to behave. Grade Group runs from 1 to 5, and the difference between them changes the treatment conversation entirely. A Grade Group 1 cancer may be safely monitored, while a Grade Group 4 or 5 cancer usually needs active treatment.
The report is read alongside:
- PSA level and MRI findings
- The number and location of positive cores, and how much of each core is involved
- Age, general health and family history
Together, these determine a risk category, which is what actually drives the treatment decision. This is why two men with the same PSA can be advised very differently.
Who Should Consider Earlier Screening?
Age is the starting point, but risk changes when the discussion should begin.
| Risk profile | When the conversation usually starts |
|---|---|
| Average risk, with no family history | Around age 50 |
| Father or brother with prostate cancer | Around age 45 |
| First-degree relative diagnosed young, or several affected relatives | Around age 40 to 45 |
| Known inherited genetic changes, such as BRCA2 | Around age 40 |
| Previous abnormal PSA result | As advised, regardless of age |
A family history of breast or ovarian cancer also matters, since some of the same inherited genetic changes raise prostate cancer risk. Men in these groups should start screening earlier rather than waiting for a symptom or a routine check-up to prompt it.
These are starting points for a discussion, not automatic instructions to test. Whether testing is appropriate depends on overall health and life expectancy as well as individual risk.
Why This Matters Particularly in India
India has no organised prostate cancer screening programme, and PSA testing is not a routine part of most health check-ups. Awareness among men is low, and the symptoms that eventually prompt a visit are usually assumed to be ordinary ageing.
The consequence is that a substantial proportion of men in India are diagnosed at a locally advanced or metastatic stage, when the aim of treatment shifts from cure to control. In countries where testing is common, far more cancers are found while still confined to the gland.
This makes the individual conversation more important, not less. Since no system will prompt a man to be tested, the prompt has to come from him, his family doctor, or a family member who knows the history.
"In India there is no organised prostate screening, and most men have never had a PSA done. That is a large part of why we still see this disease presenting late."
Dr. Himanshu Sharma, Consultant Urologist and Robotic Uro-Oncologist
What If PSA Is Normal, or Keeps Rising?
A normal PSA is reassuring but does not rule out cancer entirely, since PSA is not a perfect test and a minority of significant cancers occur without raising it. Examination findings still matter, which is why a digital rectal examination is usually performed alongside the blood test.
A rising PSA does not automatically mean cancer either. Benign enlargement raises PSA gradually over years as the gland grows. What draws attention is the pattern: a consistent upward trend, or a rise that outpaces what gland size alone would explain, is more informative than any single value.
This is why many men are simply offered periodic testing rather than immediate investigation, and why previous reports are worth keeping. The trend over time often carries more information than the latest number.
What Happens If Prostate Cancer Is Confirmed?
A diagnosis does not automatically mean immediate surgery. Treatment depends on grade, stage, risk category, age and overall health, and may include:
- Active surveillance for selected low-risk cancers
- Surgery, including robotic radical prostatectomy for suitable localised disease
- Radiotherapy, with or without hormone therapy
- Hormone therapy or other systemic treatments for advanced disease
- A combination of approaches
Active surveillance deserves particular mention, because men often assume a cancer diagnosis means an operation. It means monitoring a low-risk cancer with regular PSA tests, imaging and repeat biopsies, and intervening only if it shows signs of becoming more aggressive. For the right patient, it avoids the side effects of treatment he did not need.
Higher-risk localised disease is more often treated actively, and the choice between surgery and radiotherapy is made with the patient after discussing the different side-effect profiles.
Why Early Detection Matters
The goal is not finding cancer at any cost. Prostate cancer behaves very differently from man to man, and some cancers would never have caused harm in a man's lifetime. Treating those does more damage than good.
The aim of modern assessment is more specific: to catch clinically significant cancers early enough for treatment to work, while sparing men unnecessary biopsies and unnecessary treatment. That is precisely why PSA is no longer acted on alone, and why MRI and risk stratification now sit between the blood test and the biopsy.
"Almost every prostate cancer I can treat with the best outcomes is one that was found before the man felt anything. By the time symptoms bring someone to me, the conversation has usually changed."
Dr. Himanshu Sharma, Consultant Urologist and Robotic Uro-Oncologist
Questions Worth Asking Your Urologist
- What does my PSA mean for my age, and should I repeat the test?
- What is my PSA density, given my prostate size?
- Do I need a prostate MRI, and what would the result mean?
- If a biopsy is needed, would it be transperineal or transrectal, and why?
- If cancer is found, what is my Grade Group and risk category?
- Could active surveillance be appropriate in my case?
- Should anyone else in my family be screened earlier because of this?
Bringing previous PSA reports to the consultation genuinely helps, since changes over time often carry more information than a single result.
What This Means for You
Prostate cancer does not announce itself through pain or urinary symptoms, and waiting for a symptom is waiting too long. For most men, finding it early starts with a PSA test and an examination, moves to a prostate MRI if something looks concerning, and may lead to a targeted fusion biopsy to confirm what is there.
If you are over 50, or over 45 with a family history, the test itself takes minutes. The conversation about what the result means is the part worth having properly.
Dr. Himanshu Sharma specialises in prostate cancer evaluation and treatment, including PSA assessment, prostate MRI, MRI fusion biopsy and robotic surgery for appropriate candidates.
FAQs
Does a raised PSA always mean cancer?
No. PSA can rise due to benign enlargement, inflammation, infection, recent procedures or other factors. Benign enlargement is the commonest cause, and the result is interpreted in context before deciding on repeat testing, MRI or biopsy.
At what age should PSA screening start?
There is no single age for every man. Discussion commonly begins around 50 at average risk, around 45 with a father or brother affected, and around 40 to 45 with a relative diagnosed young or a known inherited genetic risk.
Can prostate cancer exist without urinary symptoms?
Yes. Early prostate cancer usually causes no noticeable symptoms, which is the main reason screening can find cancers before they declare themselves.
Is an MRI enough to diagnose prostate cancer?
No. MRI identifies suspicious areas and guides the biopsy, but a biopsy is needed to confirm the diagnosis. A reassuring MRI can, however, mean a biopsy is not required.
What is an MRI fusion biopsy?
It combines earlier MRI images with real-time ultrasound during the biopsy, allowing suspicious areas to be targeted while systematic sampling continues.
Is a transperineal biopsy better than a transrectal one?
The transperineal route avoids passing the needle through the bowel, which substantially lowers the risk of serious infection, and reaches the front of the gland more reliably. Many centres now prefer it.
Does a prostate cancer diagnosis always mean surgery?
No. Low-risk cancers may be monitored through active surveillance, and radiotherapy is an alternative to surgery for many localised cancers.
